Christi Shaw
CIK 1702473 · Executive Chairperson · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.44M
Companies
5
Total Filings
23
Lifetime Open-Market Net
-$3.48M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BEAM | Director | — | $29.03 | — | $0 | 4 | 2026-06-05 |
| KYTX | Executive Chairperson | 66,741 | $8.05 | $537.6K | $0 | 5 | 2026-05-29 |
| AVTR | Director | 36,271 | $9.39 | $340.6K | $0 | 1 | 2023-05-15 |
| Avantor, Inc. (AVTRpA) Delisted | Director | 26,463 | $90.81 | $2.40M | -$381.2K | 6 | 2022-05-16 |
| LLY | SVP and Pres., Lilly Bio-Meds | 500 | $1133.00 | $566.5K | -$3.10M | 7 | 2019-05-16 |
Recent Filings · Page 3 of 3
23 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-05-31 | LLY | Sell (S) | −8,426 | -$691.8K | EDGAR |
| 2018-05-03 | LLY | Mixed | +8,426 | -$431.6K | EDGAR |
| 2017-05-08 | LLY | Grant (A) | — | $0 | EDGAR |
Showing 21–23 of 23
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.